The Healthtech O2O Summit will be held on February 1, 2018. Nearly 1,000 delegates will come to the Hong Kong Convention and Exhibition Centre for a conference featuring advances in health technology and how major medical players are adopting these technologies.
“Hong Kong has the ideal mix of health, technology and medical entrepreneurs and investors to attract world players,” said NexChange CEO Juwan Lee. “Keynote speakers, in-depth panels and pitching entrepreneurs make this event a must-attend on the global healthtech calendar.” NexChange provides an innovation ecosystem as a service, specializing in fintech, insurtech, blockchain, AI and healthtech.
Technology is brought to bear on healthcare management through exciting blockchain applications that will dramatically improve privacy and accuracy. The insurance industry is actively investing in healthtech to improve health outcomes, combining it with other insurtech advances like AI, big data and more.
Medical advances are happening in Hong Kong and world leading scientists like McGill University’s Dr Moshe Szyf, James McGill Professor and GlaxoSmithKline-CIHR Chair in Pharmacology, will speak about the work happening with his Hong Kong firm HKG epitherapeutics.
“The Personalisation of Medicine” and “Facing Ageing with Technology” are major focuses at the event. Hong Kong is the longest-lived territory in the world and an ideal place for medical research and market testing. From personalized gene therapies to combating cancer to lifestyle drivers to promote healthier populations with AI and mobile technology, Healthtech O2O is delivering cutting edge speakers and companies.
“Healthtech O2O is poised to become the centre of Asia’s healthtech ecosystem, starting in Hong Kong and spreading across the region,” said Mr Lee. “We are honoured and excited to be invited to participate by InvestHK, our partners in this venture.”
1. Dato’ Chevy Beh, CEO, BookDoc
2. Michael Bruck – Partner, SPARQ Capital
3. Al Chalabi – Director, CASP-R; and Author, “Juvenescence: Investing in the Age of Longevity”
4. Dr. Allen Chan, Co-founder, Cirina (Grail)
5. Scarlett Chen, Director of Strategic Investments, Prudential
6. Bonnie Cheung, Venture Partner, 500 Startups
7. Dr. Ngai-tseung Cheung, Chief Medical Informatics Officer, Hong Kong Hospital Authority
8. Dr. Ken Chu, Programmes Director, Biorna Quantics
9. Dr. Tak-yi Chui, Undersecretary for Food and Health, the Government of Hong Kong S.A.R.
10. Peter Ohnemus, CEO, dacadoo
11. Ildar Fazulyanov, Founder & CEO, WELL Network
12. Christopher Fisher, Managing Partner, Click Ventures
13. Darryl G. Glover, Principal and Chief Clinical Officer, iSolve
14. Dr. Justin Gregory, Founder & CEO, Biorna Quantics
15. Dr. Hanif Kanji, CEO, Sinophi Healthcare
16. Xin Yun Khor, CEO, LeadinHealth
17. Michelle Y Lai, Investor and Healthtech Consultant
18. Juwan Lee, Founder & CEO, NexChange
19. Samson Lee, Co-founder, Hong Kong Blockchain Centre
20. Dr. Hung-wing Li, Associate Professor, Department of Chemistry, Hong Kong Baptist University
21. Richard Ljuhar, Founder & CEO, ImageBiopsy Lab
22. Karin Munasinghe, Senior VP, APAC Marketing, Fresenius Medical Care
23. Dr. Youjin Na, CEO, Proteina
24. Vijay Reddy, Founder, Nubis Health
25. Rob Royea, CEO, Cyrcadia Asia Ltd.
26. Dr. Moshe Szyf, CEO, HKG Epitherapeutics Limited
27. Dr. Wei-tek Tsai, Co-founder, Hong Kong Blockchain Centre
28. Raymond Wong, Head of Investment, HKSTP
29. Seung-hee Yang, Chief Communications Officer, Proteina
30. Henry Yau, Managing Director, The University of Hong Kong Clinical Trials Centre (HKU-CTC)
31. Richard Ordman, Vice President of Global Marketing, Medix Group